Document Detail


Vaccines for pneumonia and new antiviral therapies.
MedLine Citation:
PMID:  11680115     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Influenza and pneumococcal diseases are preventable to a large extent. The Health Care Financing Agency of Medicare and the Joint Commission on Accreditation of Healthcare Organizations have made prevention of these two diseases a top priority. Immunization should remain the primary tool for prevention. When influenza epidemics appear, practitioners should be aware that effective drugs are available to treat influenza A or B if given promptly after the onset of illness.
Authors:
P A Gross
Related Documents :
11464425 - Decomposing pharmaceutical cost growth in different types of health plans.
16502815 - Pfizer and humana join forces on new medicare health support program.
10158735 - An analysis of selectivity bias in the medicare aapcc (adjusted average per capita cost).
10127415 - Physician self-referral on the fast track.
2379375 - Credentialing for international fellowships.
10337085 - Health consciousness of young people in relation to their personality.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  The Medical clinics of North America     Volume:  85     ISSN:  0025-7125     ISO Abbreviation:  Med. Clin. North Am.     Publication Date:  2001 Nov 
Date Detail:
Created Date:  2001-10-26     Completed Date:  2001-12-04     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  2985236R     Medline TA:  Med Clin North Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1531-44     Citation Subset:  AIM; IM    
Affiliation:
Department of Internal Medicine, Hackensack University Medical Center, Hackensack, New Jersey, USA. pgross237@aol.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetamides / therapeutic use
Adult
Aged
Amantadine / therapeutic use
Antiviral Agents / adverse effects,  therapeutic use*
Centers for Medicare and Medicaid Services (U.S.)
Child
Guanidines
Health Priorities
Humans
Incidence
Influenza Vaccines
Joint Commission on Accreditation of Healthcare Organizations
Morbidity
Neuraminidase / antagonists & inhibitors
Oseltamivir
Patient Selection
Pneumococcal Vaccines
Pneumonia / epidemiology,  immunology,  prevention & control*
Primary Prevention / methods
Pyrans
Rimantadine / therapeutic use
Safety
Sialic Acids / therapeutic use
United States / epidemiology
Vaccination / adverse effects,  methods*
World Health
Zanamivir
Chemical
Reg. No./Substance:
0/Acetamides; 0/Antiviral Agents; 0/Guanidines; 0/Influenza Vaccines; 0/Oseltamivir; 0/Pneumococcal Vaccines; 0/Pyrans; 0/Sialic Acids; 13392-28-4/Rimantadine; 139110-80-8/Zanamivir; 768-94-5/Amantadine; EC 3.2.1.18/Neuraminidase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Nonresolving pneumonia and mimics of pneumonia.
Next Document:  Risk factors for nosocomial pneumonia. Focus on prophylaxis.